Clinical presentation and diagnosis of uterine sarcoma, including imaging

被引:76
作者
Wu, Tzu-I [1 ,2 ]
Yen, Tzu-Chen [3 ]
Lai, Chyong-Huey [1 ,2 ]
机构
[1] Chang Gung Mem Hosp, Dept Obstet & Gynecol, Tao Yuan 333, Taiwan
[2] Chang Gung Univ, Tao Yuan, Taiwan
[3] Chang Gung Mem Hosp, Dept Nucl Med, Lin Kou Med Ctr, Tao Yuan 333, Taiwan
关键词
uterine sarcoma; diagnosis; ultrasonography; magnetic resonance imaging; positron emission tomography; POSITRON-EMISSION-TOMOGRAPHY; ENDOMETRIAL STROMAL SARCOMA; TRANSVAGINAL 3-DIMENSIONAL ULTRASONOGRAPHY; GYNECOLOGIC-ONCOLOGY-GROUP; POWER DOPPLER ANGIOGRAPHY; SMOOTH-MUSCLE TUMORS; PROGNOSTIC-FACTORS; F-18; FLUORODEOXYGLUCOSE; CLINICOPATHOLOGICAL MULTICENTER; VASCULARITY MEASUREMENTS;
D O I
10.1016/j.bpobgyn.2011.07.002
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Uterine sarcomas are uncommon tumours from mesenchymal elements. They are thought to arise primarily from endometrial stroma and uterine muscle, respectively. When endometrial stroma undergoes malignant transformation, it might be accompanied by a malignant epithelial component. Thus, malignant mesenchymal uterine tumours comprise leiomyosarcoma, endometrial stromal sarcoma, undifferentiated uterine sarcoma and carcinosarcoma. In this chapter, we discusses preoperative presentation, diagnosis and current progress in different imaging modalities, including ultrasonography, computed tomography, magnetic resonance image and positron emission tomography scan. We summarise advances in new technology, which might improve preoperative detection and enhance referral to gynaecologic oncologists for optimal staging surgery and treatment. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:681 / 689
页数:9
相关论文
共 59 条
  • [1] Endometrial volume and vascularity measurements by transvaginal 3-dimensional ultrasonography and power Doppler angiography in stimulated and tumoral endometria -: An interobserver reproducibility study
    Alcázar, JL
    Mercé, LT
    Manero, MG
    Bau, S
    López-García, G
    [J]. JOURNAL OF ULTRASOUND IN MEDICINE, 2005, 24 (08) : 1091 - 1098
  • [2] Alcazar JL, 2009, AM J OBSTET GYNECOL, V200, pe44e1
  • [3] Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer
    Amant, F
    Cadron, I
    Fuso, L
    Berteloot, P
    de Jonge, E
    Jacomen, G
    Van Robaeys, J
    Neven, P
    Moerman, P
    Vergote, I
    [J]. GYNECOLOGIC ONCOLOGY, 2005, 98 (02) : 274 - 280
  • [4] Clinical management of uterine sarcomas
    Amant, Frederic
    Coosemans, An
    Debiec-Rychter, Maria
    Timmerman, Dirk
    Vergote, Ignace
    [J]. LANCET ONCOLOGY, 2009, 10 (12) : 1188 - 1198
  • [5] FIGO staging for uterine sarcomas
    不详
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2009, 104 (03) : 179 - 179
  • [6] Leiomyosarcoma of the uterus: A clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases
    Blom, R
    Guerrieri, C
    Stal, O
    Malmstrom, H
    Simonsen, E
    [J]. GYNECOLOGIC ONCOLOGY, 1998, 68 (01) : 54 - 61
  • [7] Surveillance, Epidemiology, and End Results analysis of 2677 cases of uterine sarcoma 1989-1999
    Brooks, BE
    Zhan, M
    Cote, T
    Baquet, CR
    [J]. GYNECOLOGIC ONCOLOGY, 2004, 93 (01) : 204 - 208
  • [8] Endometrial stromal sarcoma: a population-based analysis
    Chan, J. K.
    Kawar, N. M.
    Shin, J. Y.
    Osann, K.
    Chen, L-m
    Powell, C. B.
    Kapp, D. S.
    [J]. BRITISH JOURNAL OF CANCER, 2008, 99 (08) : 1210 - 1215
  • [9] Curtin J. P., 2002, PRINCIPLES PRACTICE, V919
  • [10] Uterine sarcomas: A review
    D'Angelo, Emanuela
    Prat, Jaime
    [J]. GYNECOLOGIC ONCOLOGY, 2010, 116 (01) : 131 - 139